Application of Rho Kinase Inhibitors for the Treatment of Corneal Endothelial Diseases
ROCK (Rho kinase) signaling regulates a wide spectrum of fundamental cellular events and is involved in a variety of pathological conditions. It has therefore attracted research interest as a potential therapeutic target for combating various diseases. We showed that inhibition of ROCK enhances cell...
Main Authors: | Naoki Okumura, Shigeru Kinoshita, Noriko Koizumi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2017-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2017/2646904 |
Similar Items
-
Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.
by: Hiroko Nakagawa, et al.
Published: (2015-01-01) -
Development of Poly Lactic/Glycolic Acid (PLGA) Microspheres for Controlled Release of Rho-Associated Kinase Inhibitor
by: Sho Koda, et al.
Published: (2017-01-01) -
Rho Kinase in Eye Disease
by: Naoki Okumura, et al.
Published: (2017-01-01) -
Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine.
by: Naoki Okumura, et al.
Published: (2013-01-01) -
Therapeutic potential of Rho-associated kinase inhibitor Y27632 in corneal endothelial dysfunction: an in vitro and in vivo study
by: Yao-Wen Song, et al.
Published: (2021-01-01)